RIGL Past Earnings image   This RIGL past earnings page last updated 11/7/2022
RIGL Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/3/2022-0.110
Q2 20228/2/2022-0.080
Q1 20225/3/2022-0.160
Q4 20213/1/2022-0.110
Q3 202111/2/2021-0.120
Q2 20218/3/2021-0.080
Q1 20215/5/20210.220
Q4 20203/2/2021-0.110
Q3 202011/5/2020-0.080
Q2 20208/4/2020-0.100
Q1 20205/5/20200.130
Q4 20192/27/2020-0.100
Q3 201911/5/2019-0.070
Q2 20198/6/2019-0.120
Q1 20195/7/2019-0.110
Q4 20182/28/20190.02
Q3 201811/6/2018-0.14
Q2 20188/8/2018-0.16
Q1 20185/1/2018-0.17
Q4 20173/6/2018-0.18
Q3 201711/7/2017-0.14
Q2 20178/1/2017-0.16
Q1 20175/2/2017-0.13
Q4 20163/7/2017-0.16
Q3 201611/1/2016-0.24
Q2 20168/2/2016-0.15
Q1 20165/3/2016-0.19
Q4 20153/8/2016-0.14
Q3 201511/3/2015-0.08
Q2 20158/4/2015-0.16
Q1 20155/7/2015-0.21
Q4 20143/3/2015-0.25
Q3 201411/4/2014-0.24
Q2 20148/5/2014-0.29
Q1 20145/7/2014-0.25
Q4 20133/4/2014-0.19
Q3 201311/5/2013-0.27
Q2 20138/6/2013-0.26
Q1 20135/7/2013-0.29
Q4 20123/4/2013-0.3
Q3 201211/6/2012-0.36
Q2 20128/7/2012-0.35
Q1 20125/8/2012-0.32
RIGL Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/3/20220.02B
Q2 20228/2/20220.03B
Q1 20225/3/20220.02B
Q4 20213/1/20220.02B
Q3 202111/2/20210.02B
Q2 20218/3/20210.03B
Q1 20215/5/20210.08B
Q4 20203/2/20210.02B
Q3 202011/5/20200.02B
Q2 20208/4/20200.02B
Q1 20205/5/20200.06B
Q4 20192/27/20200.02B
Q3 201911/5/20190.02B
Q2 20198/6/20190.01B
Q1 20195/7/20190.01B
Q4 20182/28/201937.86M
Q3 201811/6/20184.87M
Q2 20188/8/20181.79M
Q1 20185/1/2018NA
Q4 20173/6/2018NA
Q3 201711/7/2017900000
Q2 20178/1/2017NA
Q1 20175/2/20173.58M
Q4 20163/7/20173.00M
Q3 201611/1/20163.76M
Q2 20168/2/20168.59M
Q1 20165/3/20165.03M
Q4 20153/8/20168.54M
Q3 201511/3/201513.00M
Q2 20158/4/20155.18M
Q1 20155/7/20152.18M
Q4 20143/3/20158.25M
Q3 201411/4/2014NA
Q2 20148/5/2014NA
Q1 20145/7/2014NA
Q4 20133/4/20145.75M
Q3 201311/5/2013NA
Q2 20138/6/20131.40M
Q1 20135/7/2013NA
Q4 20123/4/2013NA
Q3 201211/6/2012NA
Q2 20128/7/20121.50M
Q1 20125/8/2012750000
Quotes delayed 20 minutes

Email EnvelopeFree RIGL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Rigel Pharmaceuticals (RIGL) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

RLAY Past Earnings
RLMD Past Earnings
RLYB Past Earnings
RMD Past Earnings
RMED Past Earnings
RMTI Past Earnings
RNA Past Earnings
RNAZ Past Earnings
RNXT Past Earnings
RPHM Past Earnings

RIGL Past Earnings Q&A

What was the best and worst RIGL past earnings results?
For Rigel Pharmaceuticals, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest RIGL past earnings result in our data set was 0.220/share posted in Q1 2021, while the lowest was in Q3 2012 when RIGL posted -0.36/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2021 when RIGL reported 0.08B in revenue, while the quarter with the lowest revenue in our data set was Q1 2018 at NA of revenue.

  Suggested answer: There are 43 RIGL past earnings results in our data set.

On this page we presented the RIGL past earnings date information for Rigel Pharmaceuticals. Reviewing that RIGL Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2021, when RIGL posted gaap of 0.220/share. Meanwhile the lowest RIGL past earnings result was in Q3 2012, when RIGL posted gaap of -0.36/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2021 when RIGL reported 0.08B in revenue, while the smallest revenue quarter was Q1 2018 when RIGL reported NA in revenue.

Any self directed investor doing their due diligence on RIGL or any other given stock can benefit from researching all of the Rigel Pharmaceuticals past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Rigel Pharmaceuticals past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for RIGL. Thanks for visiting, and the next time you need to research RIGL past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: HEAT Videos, RCON Historical Stock Prices, WNRL Videos.

 

RIGL Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.